Revenue Recognition and Accounts Receivable - Composition of Net Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total net revenue	$ 805,858	$ 804,031	$ 2,404,330	$ 2,341,943
Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	510,693	532,125	1,533,238	1,546,013
Transferred Over Time, Non-Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	262,315	271,906	774,979	795,930
Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	32,850	0	96,113	0
Sleep
Disaggregation of Revenue [Line Items]
Total net revenue	326,447	315,392	962,105	912,403
Sleep | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	237,537	227,005	696,424	656,311
Sleep | Transferred Over Time, Non-Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	81,530	88,387	244,273	256,092
Sleep | Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	7,380	0	21,408	0
Diabetes
Disaggregation of Revenue [Line Items]
Total net revenue	141,072	159,937	443,117	475,219
Diabetes | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	137,099	157,328	431,339	464,893
Diabetes | Transferred Over Time, Non-Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	2,438	2,609	7,099	10,326
Diabetes | Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	1,535	0	4,679	0
Supplies to the home
Disaggregation of Revenue [Line Items]
Total net revenue	46,780	48,349	141,983	143,227
Supplies to the home | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	43,534	48,349	132,447	143,227
Supplies to the home | Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	3,246	0	9,536	0
Respiratory
Disaggregation of Revenue [Line Items]
Total net revenue	164,017	151,083	485,305	447,815
Respiratory | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	8,148	8,164	23,723	24,284
Respiratory | Transferred Over Time, Non-Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	140,930	142,919	417,061	423,531
Respiratory | Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	14,939	0	44,521	0
HME
Disaggregation of Revenue [Line Items]
Total net revenue	52,997	52,182	157,713	154,297
HME | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	24,331	27,095	75,916	82,895
HME | Transferred Over Time, Non-Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	24,551	25,087	70,472	71,402
HME | Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	4,115	0	11,325	0
Other
Disaggregation of Revenue [Line Items]
Total net revenue	74,545	77,088	214,107	208,982
Other | Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Total net revenue	60,044	64,184	173,389	174,403
Other | Transferred Over Time, Non-Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	12,866	12,904	36,074	34,579
Other | Transferred Over Time, Capitated Arrangement
Disaggregation of Revenue [Line Items]
Total net revenue	1,635	0	4,644	0
Insurance
Disaggregation of Revenue [Line Items]
Total net revenue	490,072	486,136	1,461,224	1,397,748
Government
Disaggregation of Revenue [Line Items]
Total net revenue	208,309	220,351	617,653	618,860
Patient pay
Disaggregation of Revenue [Line Items]
Total net revenue	$ 107,477	$ 97,544	$ 325,453	$ 325,335